$8.97 5.4%
AXGN Stock Price vs. AI Score (Last 150 days)
Data gathered: July 18

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Axogen

AxoGen, Inc., together with its subsidiaries, develops and markets technologies for peripheral nerve regeneration and repair worldwide.

Price $8.97
Target Price Sign up
Volume 213,450
Market Cap $401M
Year Range $5.02 - $10.69
Dividend Yield 0%
Revenue per Employee $415,548
Industry Medical Devices

In the news

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '2441M8.8M33M-6.6M-4.5M-0.060
Q4 '2343M9.2M34M-3.9M-3.1M-0.060
Q3 '2341M8M33M-4.1M-4M0.010
Q2 '2338M7.2M31M-6.7M-6.8M-0.030
Q1 '2337M6.7M28M-7.1M-7.3M-0.100

Insider Transactions View All

Donovan Michael Patrick filed to sell 37,992 shares at $7.7.
March 25 '24
Donovan Michael Patrick filed to sell 40,221 shares at $7.7.
March 25 '24
Scopelianos Angelo filed to sell 57,994 shares at $7.7.
March 25 '24
DeVinney Erick Wayne filed to sell 165,661 shares at $7.7.
March 25 '24
DeVinney Erick Wayne filed to sell 167,890 shares at $7.7.
March 25 '24

What is the Market Cap of Axogen?

The Market Cap of Axogen is $401M.

How Many People Work at Axogen?

As of our latest update, Axogen employed approximately 394 people worldwide. However, it's important to note that Axogen's workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Axogen's revenue per employee?

$415,548. To calculate Axogen's revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of Axogen?

Currently, the price of one share of Axogen stock is $8.97.

How can I analyze the AXGN stock price chart for investment decisions?

The AXGN stock price chart above provides a comprehensive visual representation of Axogen's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Axogen shares. Our platform offers an up-to-date AXGN stock price chart, along with technical data analysis and alternative data insights.

Does AXGN offer dividends to its shareholders?

As of our latest update, Axogen (AXGN) does not offer dividends to its shareholders. Investors interested in Axogen should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Axogen?

Some of the similar stocks of Axogen are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.